Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Researchers to study health literacy among Indigenous people living with cardiovascular disease

Researchers at St. Michael's Hospital in Toronto are part of an international team of researchers recently awarded a multi-million dollar grant for their work in cardiovascular disease among Indigenous people in Canada, Australia and New Zealand. The Canadian team will receive $742,000 in funding for its part of the project from the Canadian Institutes of Health Research and International Collaborative Indigenous Health Research Partnerships.

30 Mar 2010

AlphaRx plans listing of subsidiary on Canadian exchange

AlphaRx, Inc. today announced that the Company plans to list its' Canadian subsidiary, which has been focused on China and emerging markets, on a Canadian exchange in a transaction that will result in two independent and highly focused public companies - one dedicated to the Far East and one to developed markets.

29 Mar 2010

Oxygen Biotherapeutics commences distributing newly formulated Dermacyte Oxygen Concentrate

Oxygen Biotherapeutics, Inc. today announced that the company has begun distribution for its newly formulated Dermacyte™ Oxygen Concentrate for the beauty and skin care market. The over-the-counter product is a scientifically designed perfluorocarbon concentrate to enhance oxygen delivery to skin.

29 Mar 2010

Cardima announces CE Mark approval for Surgical Ablation Probe in Surgical Treatment of Atrial Fibrillation

Cardima, Inc., a medical device company focused on the treatment of atrial fibrillation (AF) and manufacturer of the Cardima Surgical Ablation System, today announced that it has received CE Mark approval with an Indication for the Surgical Treatment of Atrial Fibrillation for its Surgical Ablation Probe. All components of the Cardima Surgical Ablation System are now approved for marketing for the treatment of AF in European countries recognizing CE Mark approval.

29 Mar 2010

Six weeks of radiotherapy to be consolidated into 30 minutes for breast cancer patients

Nearly 45 thousand women are diagnosed with breast cancer each year. Two third of these women need a combination of surgery and radiotherapy. Radiotherapy can kill cancer cells that may have been missed during operation. These remnant cells are responsible for 90% relapses.

29 Mar 2010

Your plate is laden with bad trans fats! Food Manufacturers to admit it now in a mandatory labeling bid

Trans fats are that part of your diet that can cause heart disease, diabetes, stroke, high cholesterol and are related to at least 6,000 Australian deaths each year. These fats are essentially liquid fats converted to solids by hydrogenation and thus also called hydrogenated fats.

29 Mar 2010

Pelosi releases statement after President Obama signs Senate health insurance reform legislation into law

“On Sunday night, the House of Representatives made history for our country and progress for the American people. Today, with the stroke of his pen, President Obama completed what the late Senator Edward Kennedy called ‘the great unfinished business of our society’ by signing historic health insurance reform into law.

27 Mar 2010

UCSF approach may one day be used to create new periods of plasticity in human brain

UCSF scientists report that they were able to prompt a new period of "plasticity," or capacity for change, in the neural circuitry of the visual cortex of juvenile mice. The approach, they say, might some day be used to create new periods of plasticity in the human brain that would allow for the repair of neural circuits following injury or disease.

27 Mar 2010

Pathway Genomics Genetic Health Report helps make more informed health and lifestyle decisions

You may not suffer from any form of heart disease, high blood pressure, or high cholesterol, but you could have a predisposition for these conditions based on more than just your lifestyle or diet. A family history of diabetes, gout, high blood pressure or high blood cholesterol can increase one’s risk regardless of lifestyle.

27 Mar 2010

Ford Motor donates $255,000 to fund completion of Oakwood Healthcare System's research study

Ford Motor Company announced today it is donating an additional $255,000 to fund the completion of a pioneering multi-year Oakwood Healthcare System research study into the prevention of heart disease – a leading cause of death among American women.

27 Mar 2010

READ 3 study for DME begins enrolling participants

A Phase II clinical trial for a promising treatment for diabetic eye disease has begun enrolling participants.

27 Mar 2010

Medtronic announces enrollment of first European patients in randomized controlled trial of ITB Therapy

Medtronic, Inc. today announced the enrollment of the first European patients in the largest randomized controlled trial to date to investigate the benefits of ITB Therapy(R) (Intrathecal Baclofen) in post-stroke patients affected by spasticity. The announcement comes as the World Congress for Neurorehabilitation is taking place in Vienna, Austria.

26 Mar 2010

New devices pave way for applications in cardiology and neurology

A team of cardiologists, materials scientists, and bioengineers have created and tested a new type of implantable device for measuring the heart's electrical output that they say is a vast improvement over current devices. The new device represents the first use of flexible silicon technology for a medical application.

26 Mar 2010

Pravastatin benefits elderly carriers of KIF6 gene variant with prior vascular disease

Celera Corporation today announced the publication of data reporting that elderly (over age 70) carriers of the KIF6 gene variant with prior vascular disease received significant benefit from pravastatin (Pravachol®) therapy. Previous research has shown that a variant of the KIF6 gene, a member of the molecular motor protein kinesin family, is associated with up to a 55% increased risk of primary and recurrent coronary heart disease (CHD) events in the placebo arms of the clinical trials, and that this increased risk is virtually eliminated with statin therapy.

26 Mar 2010

UK government commits £250M for proposed medical research and innovation centre

Gordon Brown has announced the government's commitment to investing £250 million in the proposed UK Centre for Medical Research and Innovation (UKCMRI).

26 Mar 2010

Mexican-American women les likely to use emergency medical services for stroke symptoms

Mexican Americans are 40 percent less likely than non-Hispanic whites to call 9-1-1 and be taken to the hospital via ambulance for stroke - resulting in medical treatment delays - according to a new study reported in Stroke: Journal of the American Heart Association.

26 Mar 2010

New topical drug may help treat diabetic eye disease

Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.

26 Mar 2010

Simultaneous implantations of BIOTRONIK's Lumax DX single-chamber ICD at six European hospitals

BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the first implantations of the Lumax DX System, a novel single-chamber ICD concept.

26 Mar 2010

Telemedicine evaluation of stroke patients results in more accurate diagnoses: Study

A growing number of medical centers that have access to stroke specialists are transmitting their expertise to rural communities via audio/video telemedicine consultation, with significant clinical results, according to a new clinical study that examined trials conducted in Arizona and California.

26 Mar 2010

NIH grants $1.4 Million to WPI to continue study of arterial plaque

A Worcester Polytechnic Institute research team has received a four-year, $1.4 million award from the National Institutes of Health to continue a groundbreaking study of arterial plaque. This research could lead to tools that will enable physicians to predict the likelihood of plaque rupture, which is responsible for most heart attacks and strokes.

25 Mar 2010

Stroke News and Research

Further Reading

Researchers to study health literacy among Indigenous people living with cardiovascular disease

AlphaRx plans listing of subsidiary on Canadian exchange

Oxygen Biotherapeutics commences distributing newly formulated Dermacyte Oxygen Concentrate

Cardima announces CE Mark approval for Surgical Ablation Probe in Surgical Treatment of Atrial Fibrillation

Six weeks of radiotherapy to be consolidated into 30 minutes for breast cancer patients

Your plate is laden with bad trans fats! Food Manufacturers to admit it now in a mandatory labeling bid

Pelosi releases statement after President Obama signs Senate health insurance reform legislation into law

UCSF approach may one day be used to create new periods of plasticity in human brain

Pathway Genomics Genetic Health Report helps make more informed health and lifestyle decisions

Ford Motor donates $255,000 to fund completion of Oakwood Healthcare System's research study

READ 3 study for DME begins enrolling participants

Medtronic announces enrollment of first European patients in randomized controlled trial of ITB Therapy

New devices pave way for applications in cardiology and neurology

Pravastatin benefits elderly carriers of KIF6 gene variant with prior vascular disease

UK government commits £250M for proposed medical research and innovation centre

Mexican-American women les likely to use emergency medical services for stroke symptoms

New topical drug may help treat diabetic eye disease

Simultaneous implantations of BIOTRONIK's Lumax DX single-chamber ICD at six European hospitals

Telemedicine evaluation of stroke patients results in more accurate diagnoses: Study

NIH grants $1.4 Million to WPI to continue study of arterial plaque

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News